A case of intraductal papillary neoplasm of the bile duct accompanied by intraductal papillary mucinous neoplasm of the pancreas and hepatocellular carcinoma.
Adenocarcinoma, Mucinous
/ diagnostic imaging
Aged
Bile Ducts
Carcinoma, Hepatocellular
/ diagnostic imaging
Carcinoma, Pancreatic Ductal
/ diagnostic imaging
Humans
Liver Neoplasms
/ diagnostic imaging
Male
Neoplasm Recurrence, Local
Pancreas
Pancreatectomy
Pancreatic Neoplasms
/ diagnostic imaging
Hepatocellular carcinoma
Intraductal papillary mucinous neoplasm of the pancreas
Intraductal papillary neoplasm of the bile duct
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
09
03
2021
accepted:
03
06
2021
pubmed:
10
6
2021
medline:
16
9
2021
entrez:
9
6
2021
Statut:
ppublish
Résumé
A 73-year-old man with mixed-type intraductal papillary mucinous neoplasm of the pancreas body was followed up for 14 years. Based on imaging findings, the intraductal papillary mucinous neoplasm of the pancreas met the high-risk stigmata, and new hepatic masses were suspected to be intraductal papillary neoplasms of the bile duct. With a diagnosis of intraductal papillary mucinous neoplasm of the pancreas and intraductal papillary neoplasm of the bile duct, the patient had undergone left lateral hepatectomy and distal pancreatectomy. Based on pathology, the pancreatic specimen was diagnosed as a high-grade intraductal papillary mucinous neoplasm of the pancreas, and the hepatic specimen was diagnosed as an intraductal papillary neoplasm of the bile duct and hepatocellular carcinoma. The intraductal papillary neoplasms of the bile duct and hepatocellular carcinoma were adjacent to each other. Fifteen months after surgery, recurrence in the remnant pancreas was detected. The patient had undergone residual total pancreatectomy, with no recurrence thirty months after the second resection. This case demonstrates that second surgery for metachronous high-risk lesions in the remnant pancreas of patients with intraductal papillary mucinous neoplasm of the pancreas and intraductal papillary neoplasm of the bile duct may also be considered to improve survival.
Identifiants
pubmed: 34106396
doi: 10.1007/s12328-021-01461-z
pii: 10.1007/s12328-021-01461-z
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1536-1543Informations de copyright
© 2021. Japanese Society of Gastroenterology.
Références
Nakanuma Y, Curabo MO, Franceschi S, et al. Intrahepatic cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. World Health Organization classification of tumours digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010. p. 217–24.
Nakanuma Y, Basturk O, Esposito I, et al. Intraductal papillary neoplasm of the bile duct. In: WHO classification of tumours editorial board. World Health Organization classification of tumours digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019. p. 279–82.
Nakanuma Y, Uesaka K, Kakuda Y, et al. Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations. J Clin Med. 2020;9:3991.
doi: 10.3390/jcm9123991
Joo YH, Kim MH, Lee SK, et al. A case of mucin-hypersecreting intrahepatic bile duct tumor associated with pancreatic intraductal papillary mucinous tumor. Gastrointest Endosc. 2000;52:409–12.
doi: 10.1067/mge.2000.108294
Ishida M, Seki K, Honda K, et al. Intraductal mucinous tumors occurring simultaneously in the liver and pancreas. J Gastroenterol. 2002;37:1073–8.
doi: 10.1007/s005350200181
Yamaguchi Y, Abe N, Imase K, et al. A case of mucin hypersecreting intraductal papillary carcinomas occurring simultaneously in liver and pancreas. Gastrointest Endosc. 2005;61:330–4.
doi: 10.1016/S0016-5107(04)02635-5
Zalinski S, Paradis V, Valla D, et al. Intraductal papillary mucinous tumors of both biliary and pancreatic ducts. J Hepatol. 2007;46:978–9.
doi: 10.1016/j.jhep.2007.02.005
Xu XW, Li RH, Zhou W, et al. Laparoscopic resection of synchronous intraductal papillary mucinous neoplasms: a case report. World J Gastroenterol. 2012;18:6510–4.
doi: 10.3748/wjg.v18.i44.6510
Date K, Ohtsuka T, Fujimoto T, et al. GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual: a case report. Pancreatology. 2015;15:713–6.
doi: 10.1016/j.pan.2015.09.013
Bansal A, Thung SN, Zhu H, et al. Synchronous pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma arising in the context of intraductal papillary neoplasms. Clin Imaging. 2016;40:897–901.
doi: 10.1016/j.clinimag.2015.12.019
Luvira V, Pugkhem A, Tipwaratorn T, et al. Simultaneous extensive intraductal papillary neoplasm of the bile duct and pancreas: a very rare entity. Case Rep Surg. 2016;2016:1–6.
doi: 10.1155/2016/1518707
Ren X, Zhu C-L, Qin X-F, et al. Co-occurrence of IPMN and malignant IPNB complicated by a pancreatobiliary fistula: a case report and review of the literature. World J Clin Cases. 2019;7:102–8.
doi: 10.12998/wjcc.v7.i1.102
Tanaka M, Fernández-del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.
doi: 10.1016/j.pan.2017.07.007
Luvira V, Pugkhem A, Bhudhisawasdi V, et al. Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct. J Gastroenterol Hepatol. 2017;32:527–33.
doi: 10.1111/jgh.13481
Kim JR, Jang K-T, Jang J-Y, et al. Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study. HPB. 2020;22:1139–48.
doi: 10.1016/j.hpb.2019.11.007
Nakanuma Y, Jang K-T, Fukushima N, et al. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci. 2018;25:181–7.
doi: 10.1002/jhbp.532
Nakanuma Y, Sudo Y. Biliary tumors with pancreatic counterparts. Semin Diagn Pathol. 2017;34:167–75.
doi: 10.1053/j.semdp.2016.12.013
Kubota K, Jang JY, Nakanuma Y, et al. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study. J Hepatobiliary Pancreat Sci. 2020;27:581–97.
doi: 10.1002/jhbp.785
Nakanuma Y, Uesaka K, Terada T, et al. Gastric subtype of intraductal papillary neoplasm of the bile duct: the pathologic spectrum. J Hepatobiliary Pancreat Sci. 2020;27:402–13.
doi: 10.1002/jhbp.751
Hirono S, Shimizu Y, Ohtsuka T, et al. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol. 2020;55:86–99.
doi: 10.1007/s00535-019-01617-2
Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571–80.
doi: 10.1097/MPA.0b013e318215010c
Xu J, Sato Y, Harada K, et al. Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma. World J Gastroenterol. 2011;17:1923–6.
doi: 10.3748/wjg.v17.i14.1923